Anbio Biotechnology (NASDAQ:NNNN) Hits New 1-Year Low – Here’s Why

Anbio Biotechnology (NASDAQ:NNNN) shares hit a new 52-week low during trading on Thursday . The company traded as low as $6.55 and last traded at $6.51, with a volume of 64932 shares changing hands. The stock had previously closed at $6.85.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings downgraded Anbio Biotechnology from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Wednesday, July 29th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company has an average rating of “Sell”.

Anbio Biotechnology Trading Down 5.7%

The stock has a fifty day moving average of $9.99 and a two-hundred day moving average of $19.62.

Anbio Biotechnology Company Profile

Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs.